CTOs on the Move

HepaHope

www.hepahope.com

 
HepaHope is a Irvine, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.hepahope.com
  • 30 Fairbanks Ste 110
    Irvine, CA USA 92618
  • Phone: 949.421.3600

Executives

Name Title Contact Details

Similar Companies

ContextVision

ContextVision is a leading provider of medical image enhancement software to global equipment manufacturers. With its versatile GOP® technology at the core of its extensive product line, ContextVision enables its customers to offer clinicians unparalleled diagnostic image quality, ultimately providing patients with better care. ContextVision was established in 1983 by a specialist research team at Linköping University in Sweden. The university has been a center for digital image research and analysis. ContextVision, now considered the gold standard of medical image enhancement, offers a powerful combination of sophisticated technology and team expertise within ultrasound, x-ray, magnetic resonance imaging, mammography, interventional radiology and computed tomography. More than 150,000 systems across the globe rely on ContextVision`s market-leading products for 2D, 3D, or 4D image enhancements. Its dynamic group of image-enhancement experts customize installations for optimal image quality.

F2 Creations

F2 Creations is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical Cost Management

Medical Cost Management Corp. is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tunstall Healthcare

Tunstall Healthcare is a San Jose, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Astellas Gene Therapies

Astellas Gene Therapies is an Astellas Center of Excellence developing genetic medicines with the potential to deliver transformative value for patients. Based on an innovative scientific approach and industry leading internal manufacturing capability and expertise, we are currently exploring three gene therapy modalities: gene replacement, exon skipping gene therapy, and vectorized RNA knockdown and will also advance additional Astellas gene therapy programs toward clinical investigation. We are based in San Francisco, with manufacturing and laboratory facilities in South San Francisco and Sanford, North Carolina.